The Importance of Omega-3 Fatty Acids in the Management and Rehabilitation of Depressive Disorders
DOI:
https://doi.org/10.56294/hl2024.397Keywords:
polyunsaturated fatty acids (PUFA), Omega-3 Fatty Acids, eicosapentaenoic acid (EPA), major depressive disorder (MDD)Abstract
Background: Omega-3 “polyunsaturated fatty acids (PUFA)” supplementation in depressed individuals has been advocated as a way to reduce depression symptoms, however prior research has been unambiguous.
Objectives: To the latest meta-analysis of "randomized controlled trials (RCTs)" investigating the usefulness of omega-3 PUFAs in the treatment of depressive illnesses while accounting for clinical variations among the research patients.
Methods: RCTs employing PUFA omega-3 on individuals with depression symptoms were searched for in PsycINFO, Cochrane Database, MEDLINE, and EMBASE. The research to normalize average variation in psychological assessments for mental health intensity, investigate the use of omega-3 as monotherapy or in combination, concentrate on eicosapentaenoic acid [EPA] and docosahexaenoic acid [DHA]. Impacts of this research scope, initial level of depression, length of the hearings, omega-3 dose, and patient gender were evaluated using a meta-analysis.
Results: The considerable therapeutic advantage of PUFA omega-3 therapy in contrast to placebo was seen in a meta-analysis of 11 and 8 studies PUFA omega-3 on those who have of “major depressive disorder (MDD)” and patients through depressed symptoms without diagnosis of MDD. Ultimately effectiveness was modified using predominantly EPA relatively DHA in the formulation. When used as an auxiliary rather than a monotherapy, omega-3 PUFA has shown considerable beneficial effects. There was no association among investigation dimensions, beginning depressive extent, treatment time, client ages, or research effectiveness. Research on omega-3 PUFAs' effectiveness in treating bipolar disorder, perinatal depression, and primary diseases is limited, highlighting the need for further investigations.
References
1. Giacobbe J, Benoiton B, Zunszain P, Pariante CM, Borsini A. The anti-inflammatory role of omega-3 polyunsaturated fatty acids metabolites in pre-clinical models of psychiatric, neurodegenerative, and neurological disorders. Frontiers in Psychiatry. 2020 Feb 28;11:450833. https://doi.org/10.3389/fpsyt.2020.00122
2. Wolters M, von der Haar A, Baalmann AK, Wellbrock M, Heise TL, Rach S. Effects of n-3 polyunsaturated fatty acid supplementation in the prevention and treatment of depressive disorders—a systematic review and meta-analysis. Nutrients. 2021 Mar 25;13(4):1070. https://doi.org/10.3390/nu13041070
3. Wojdasiewicz P, Poniatowski ŁA, Turczyn P, Frasuńska J, Paradowska-Gorycka A, Tarnacka B. Significance of Omega‐3 Fatty Acids in the Prophylaxis and Treatment after Spinal Cord Injury in Rodent Models. Mediators of Inflammation. 2020;2020(1):3164260. https://doi.org/10.1155/2020/3164260
4. Bozzatello P, Brignolo E, De Grandi E, Bellino S. Supplementation with omega-3 fatty acids in psychiatric disorders: a review of literature data. Journal of clinical medicine. 2016 Jul 27;5(8):67. https://doi.org/10.3390/jcm5080067
5. Ouyang WC, Sun GC, Hsu MC. Omega-3 fatty acids in cause, prevention and management of violence in schizophrenia: Conceptualization and application. Aggression and violent behavior. 2020 Jan 1;50:101347. https://doi.org/10.1016/j.avb.2019.101347
6. Rodríguez-Iglesias N, Nadjar A, Sierra A, Valero J. Susceptibility of female mice to the dietary omega-3/Omega-6 fatty-acid ratio: effects on adult hippocampal neurogenesis and glia. International Journal of Molecular Sciences. 2022 Mar 21;23(6):3399. https://doi.org/10.3390/ijms23063399
7. Trebatická J, Hradečná Z, Surovcová A, Katrenčíková B, Gushina I, Waczulíková I, Sušienková K, Garaiova I, Šuba J, Ďuračková Z. Omega-3 fatty-acids modulate symptoms of depressive disorder, serum levels of omega-3 fatty acids and omega-6/omega-3 ratio in children. A randomized, double-blind and controlled trial. Psychiatry research. 2020 May 1;287:112911. https://doi.org/10.1016/j.psychres.2020.112911
8. Guu TW, Mischoulon D, Sarris J, Hibbeln J, McNamara RK, Hamazaki K, Freeman MP, Maes M, Matsuoka YJ, Belmaker RH, Marx W. A multi-national, multi-disciplinary Delphi consensus study on using omega-3 polyunsaturated fatty acids (n-3 PUFAs) for the treatment of major depressive disorder. Journal of affective disorders. 2020 Mar 15;265:233-8. https://doi.org/10.1016/j.jad.2020.01.050
9. Rittenhouse M, Sambuughin N, Deuster P. Optimization of Omega-3 Index Levels in Athletes at the US Naval Academy: Personalized Omega-3 Fatty Acid Dosage and Molecular Genetic Approaches. Nutrients. 2022 Jul 20;14(14):2966. https://doi.org/10.3390/nu14142966
10. Tomczyk M, Jost Z, Chroboczek M, Urbański R, Calder PC, Fisk HL, Sprengel M, Antosiewicz J. Effects of 12 wk of Omega-3 fatty acid supplementation in Long-Distance runners. Medicine and science in sports and exercise. 2022 Sep 27;55(2):216. https://doi.org/10.1249/MSS.0000000000003038
11. Checa-Ros A, D’Marco L. Role of omega-3 fatty acids as non-photic zeitgebers and circadian clock synchronizers. International journal of molecular sciences. 2022 Oct 12;23(20):12162. https://doi.org/10.3390/ijms232012162
12. van Verseveld M, Mocking RJ, Scheepens D, Ten Doesschate F, Westra M, Schoevers RA, Schene AH, van Wingen GA, van Waarde JA, Ruhé HG. Polyunsaturated fatty acids changes during electroconvulsive therapy in major depressive disorder. Journal of Psychiatric Research. 2023 Apr 1;160:232-9. https://doi.org/10.1016/j.jpsychires.2023.02.028
13. Xia DN, Tan YQ, Yang JY, Zhou G. Omega-3 polyunsaturated fatty acids: a promising approach for the management of oral lichen planus. Inflammation Research. 2020 Oct;69:989-99. https://doi.org/10.1007/s00011-020-01388-0
14. Ouyang WC, Sun GC, Hsu MC. Omega-3 fatty acids in cause, prevention and management of violence in schizophrenia: Conceptualization and application. Aggression and violent behavior. 2020 Jan 1;50:101347. https://doi.org/10.1016/j.avb.2019.101347
15. Kapoor B, Kapoor D, Gautam S, Singh R, Bhardwaj S. Dietary polyunsaturated fatty acids (PUFAs): Uses and potential health benefits. Current nutrition reports. 2021 Sep;10:232-42. https://doi.org/10.1007/s13668-021-00363-3
16. Liang Z, Lou Y, Li Z, Liu S. Causal relationship between human blood omega-3 fatty acids and the risk of epilepsy: A two-sample Mendelian randomization study. Frontiers in Neurology. 2023 Mar 9;14:1130439. https://doi.org/10.3389/fneur.2023.1130439
17. Zailani H, Satyanarayanan SK, Liao WC, Liao HF, Huang SY, Gałecki P, Su KP, Chang JP. Omega-3 polyunsaturated fatty acids in managing comorbid mood disorders in chronic obstructive pulmonary disease (COPD): a review. Journal of Clinical Medicine. 2023 Apr 2;12(7):2653. https://doi.org/10.3390/jcm12072653
18. Déniz C, Raba-Parodi C, García-Raimundo E, Macía I, Rivas F, Ureña A, Muñoz A, Moreno C, Serratosa I, Masuet-Aumatell C, Escobar I. Preoperative omega-6/omega-3 fatty acid ratio could predict postoperative outcomes in patients with surgically resected non-small-cell lung cancer. Current Oncology. 2022 Sep 28;29(10):7086-98. https://doi.org/10.3390/curroncol29100556
19. Katrenčíková B, Vaváková M, Waczulíková I, Oravec S, Garaiova I, Nagyová Z, Hlaváčová N, Ďuračková Z, Trebatická J. Lipid profile, lipoprotein subfractions, and fluidity of membranes in children and adolescents with depressive disorder: Effect of omega-3 fatty acids in a double-blind randomized controlled study. Biomolecules. 2020 Oct 8;10(10):1427. https://doi.org/10.3390/biom10101427
20. Perić I, Lješević M, Beškoski V, Nikolić M, Filipović D. Metabolomic profiling relates tianeptine effectiveness with hippocampal GABA, myo-inositol, cholesterol, and fatty acid metabolism restoration in socially isolated rats. Psychopharmacology. 2022 Sep;239(9):2955-74. https://doi.org/10.1007/s00213-022-06180-y
21. González AP, Flores-Ramírez A, Gutiérrez-Castro KP, Luévano-Contreras C, Gómez-Ojeda A, Sosa-Bustamante GP, Caccavello R, Barrera-de León JC, Garay-Sevilla ME, Gugliucci A. Reduction of small dense LDL and Il-6 after intervention with Plantago psyllium in adolescents with obesity: a parallel, double blind, randomized clinical trial. European journal of pediatrics. 2021 Aug;180:2493-503. https://doi.org/10.1007/s00431-021-04064-5
22. Zorgetto-Pinheiro VA, Machate DJ, Figueiredo PS, Marcelino G, Hiane PA, Pott A, Guimarães RD, Bogo D. Omega-3 fatty acids and balanced gut microbiota on chronic inflammatory diseases: A close look at ulcerative colitis and rheumatoid arthritis pathogenesis. Journal of Medicinal Food. 2022 Apr 1;25(4):341-54. https://doi.org/10.1089/jmf.2021.0012
23. Frasure-Smith N, Lespérance F, Julien P. Major depression is associated with lower omega-3 fatty acid levels in patients with recent acute coronary syndromes. Biological psychiatry. 2004 May 1;55(9):891-6. https://doi.org/10.1016/j.biopsych.2004.01.021
24. Ciappolino V, Delvecchio G, Agostoni C, Mazzocchi A, Altamura AC, Brambilla P. The role of n-3 polyunsaturated fatty acids (n-3PUFAs) in affective disorders. Journal of affective disorders. 2017 Dec 15;224:32-47. https://doi.org/10.1016/j.jad.2016.12.034
25. Freeman MP, Hibbeln JR, Wisner KL, Davis JM, Mischoulon D, Peet M, Keck Jr PE, Marangell LB, Richardson AJ, Lake J, Stoll AL. Omega-3 fatty acids: evidence basis for treatment and future research in psychiatry. Journal of Clinical psychiatry. 2006 Dec 15;67(12):1954.
26. Turnbull T, Cullen-Drill M, Smaldone A. Efficacy of omega-3 fatty acid supplementation on improvement of bipolar symptoms: a systematic review. Archives of psychiatric nursing. 2008 Oct 1;22(5):305-11. https://doi.org/10.1016/j.apnu.2008.02.011
27. Li GR, Sun HY, Zhang XH, Cheng LC, Chiu SW, Tse HF, Lau CP. Omega-3 polyunsaturated fatty acids inhibit transient outward and ultra-rapid delayed rectifier K+ currents and Na+ current in human atrial myocytes. Cardiovascular research. 2009 Feb 1;81(2):286-93. https://doi.org/10.1093/cvr/cvn322
28. O'Neill B, Hafiz MA, De Beer DA. Corrosion of Penlon sevoflurane vaporisers. Anaesthesia. 2007 Apr;62(4):421-. https://doi.org/10.1111/j.1365-2044.2007.05048.x
29. Harvey MG, Cave GR. Intralipid infusion ameliorates propranolol-induced hypotension in rabbits. Journal of Medical Toxicology. 2008 Jun;4:71-6. https://doi.org/10.1007/BF03160958.
Published
Issue
Section
License
Copyright (c) 2024 Manisha Chandna, Sidhant Das, Malathi H, Neha Rana, Geetika Madan Patel, Snehanshu Dey, N.J.Patil (Author)
This work is licensed under a Creative Commons Attribution 4.0 International License.
The article is distributed under the Creative Commons Attribution 4.0 License. Unless otherwise stated, associated published material is distributed under the same licence.
